U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies

Amphastar Pharmaceuticals

Market Cap: US$871.6m

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

Travere Therapeutics

Market Cap: US$2.7b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Curaleaf Holdings

Market Cap: US$2.4b

Engages in the retail and wholesale of cannabis products in the United States and internationally.

Merck KGaA

Market Cap: US$48.3b

Operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.

Zevra Therapeutics

Market Cap: US$535.4m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

High Tide

Market Cap: US$294.3m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Catalyst Pharmaceuticals

Market Cap: US$3.0b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

CorMedix

Market Cap: US$518.6m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Verano Holdings

Market Cap: US$552.1m

Operates as a vertically integrated multi-state cannabis operator in the United States.

MDxHealth

Market Cap: US$173.6m

A commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally.

Elanco Animal Health

Market Cap: US$11.9b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Bio-Rad Laboratories

Market Cap: US$7.3b

Develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.

Ardelyx

Market Cap: US$1.5b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

Collegium Pharmaceutical

Market Cap: US$1.2b

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

IQVIA Holdings

Market Cap: US$30.0b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Daiichi Sankyo Company

Market Cap: US$5.3t

Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.

Fennec Pharmaceuticals

Market Cap: US$259.2m

Operates as a commercial stage biopharmaceutical company in the United States.

Perrigo

Market Cap: US$1.4b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Alkermes

Market Cap: US$4.7b

A biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

Grifols

Market Cap: US$6.0b

Engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally.

Exelixis

Market Cap: US$11.0b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

BioNTech

Market Cap: US$25.6b

A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.

Bayer

Market Cap: US$39.1b

Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.

Protara Therapeutics

Market Cap: US$308.1m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

CSL

Market Cap: US$69.5b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Avantor

Market Cap: US$5.6b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Cresco Labs

Market Cap: US$624.3m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

Daiichi Sankyo Company

Market Cap: US$5.3t

Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.

TG Therapeutics

Market Cap: US$4.3b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Telix Pharmaceuticals

Market Cap: US$3.7b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

Evotec

Market Cap: US$833.8m

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Vanda Pharmaceuticals

Market Cap: US$513.1m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

ACADIA Pharmaceuticals

Market Cap: US$3.8b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

Viatris

Market Cap: US$16.4b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Qiagen

Market Cap: US$8.9b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Trulieve Cannabis

Market Cap: US$1.7b

Operates as a cannabis retailer in the United States.